Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13286460 | 0.86 | RECQL (0.57) | RECQLTSHRGAALMNAKDM4E | |
| SCHEMBL2754583 | 0.86 | RECQL (0.69) | RECQLTSHRTET2GAALMNA | |
| SCHEMBL23085256 | 0.86 | RECQL (0.83) | RECQLTSHRTET2GAALMNA | |
| SCHEMBL19448715 | 0.86 | TSHR (0.62) | RECQLTSHRTET2LMNAKDM4E | |
| SCHEMBL13188964 | 0.86 | RECQL (0.57) | RECQLTSHRTET2GAALMNA | |
| SCHEMBL125974 | 0.86 | GAA (0.70) | RECQLTSHRGAALMNAKDM4E | |
| SCHEMBL810809 | 0.84 | RECQL (0.72) | RECQLTSHRTET2GAAALDH1A1 | |
| SCHEMBL13246470 | 0.83 | RECQL (0.64) | RECQLTSHRTET2GAALMNA | |
| SCHEMBL9560019 | 0.82 | RECQL (0.69) | RECQLTSHRTET2GAAKDM4E | |
| SCHEMBL22345240 | 0.82 | RECQL (0.69) | RECQLTSHRTET2GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4589059-A2 | PROCESS FOR MICROSATELLITE INSTABILITY DETECTION | Personal Genome Diagnostics, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-3717520-B1 | PROCESS FOR MICROSATELLITE INSTABILITY DETECTION | PERSONAL GENOME DIAGNOSTICS INC (US) | 2025-04-16 | — | — | EP | disclosed |
| US-20240124889-A1 | COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION | VOYAGER THERAPEUTICS, INC. | 2024-04-18 | — | — | US | disclosed |
| CN-117744101-A | Method and system for acquiring encrypted key data of converter secondary smelting process based on image recognition mode | 河钢乐亭钢铁有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20230160002-A1 | Process for Microsatellite Instability Detection | Personal Genome Diagnostics Inc. (US) | 2023-05-25 | — | — | US | disclosed |
| US-11597967-B2 | Process for microsatellite instability detection | Personal Genome Diagnostics Inc. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20220389449-A1 | COMPOSITIONS FOR THE TREATMENT OF DISEASE | VOYAGER THERAPEUTICS, INC. | 2022-12-08 | — | — | US | disclosed |
| US-11326182-B2 | Compositions for the treatment of disease | VOYAGER THERAPEUTICS, INC. (US) | 2022-05-10 | — | — | US | disclosed |